Compare Mutual Funds
Pros | Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 5Y returns in the bottom 25% of the category. | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 5/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 6 Years 10 Months | 13 Years 6 Months | ||
Fund AUM | ₹859 Cr | ₹7898 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 1.02% | 0.93% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 39 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 97.65% | 99.46% | ||
Debt % | - | - | ||
P/E | 36.85 | 34.36 | ||
P/B | 5.51 | 5.45 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 3.72% | 4.47% | ||
3-Month Return | 8.5% | 7.61% | ||
6-Month Return | 1.62% | 0.72% | ||
1-Year Return | 7.24% | 5.12% | ||
3-Year Return | 24.53% | 23.29% | ||
5-Year Return | 14.37% | 14.67% |
Sharpe | 1.05 | 1 | ||
Alpha | 0.78 | -0.11 | ||
Beta | 0.92 | 0.91 | ||
Standard Deviation | 16.07 | 15.72 | ||
Information Ratio | -0.12 | -0.48 |
Description | Aditya Birla Sun Life Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dhaval Shah | Amber Singhania, Sailesh Raj Bhan, Kinjal Desai |

